• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 485210 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1419300281 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1419300281 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Bristol-Myers Squibb: The Winning Streak Continues (BMY)

Published on Tue, 04/23/2013 - 14:13
By Peter Chu

Bristol-Myers Squibb (NYSE:BMY) traded today at a new 52-week high of $42.87. So far today approximately 7.2 million shares have been exchanged, as compared to an average 30-day volume of 10.1 million shares.

Bristol-Myers Squibb (NYSE:BMY) defies analysts with a current price ($42.39) 13.7% above its average consensus price target of $36.57. The stock should find initial support at its 50-day moving average (MA) of $38.96 and further support at its 200-day MA of $34.92.

In the past 52 weeks, shares of Bristol-Myers Squibb have traded between a low of $30.64 and a high of $42.87 and are now at $42.39, which is 38% above that low price. The 200-day and 50-day moving averages have moved 0.24% higher and 0.73% higher over the past week, respectively.

Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Watch for Continued Gains in Shares of T...

Shares of T Rowe Price (NASDAQ:TROW) traded today at $87.45, breaking its 52-week high. ...

Shares of TriQuint Semiconductor Rise to...

Shares of TriQuint Semiconductor (NASDAQ:TQNT) traded today at $27.36, breaking its 52- ...

TJX Cos: The Winning Streak Continues (T...

TJX Cos (NYSE:TJX) traded today at a new 52-week high of $67.49. This new high was rea ...

TreeHouse Foods: The Winning Streak Cont...

Shares of TreeHouse Foods (NYSE:THS) traded at a new 52-week high today of $88.52. So ...

Recent 52-Week High Exceeded in Shares o...

Taser International (NASDAQ:TASR) traded at a new 52-week high today of $26.39. So far ...

TravelCenters of America Looks to Contin...

Shares of TravelCenters of America (AMEX:TA) traded at a new 52-week high today of $12. ...

Recent 52-Week High Exceeded in Shares o...

Shares of Sensient Technologies (NYSE:SXT) traded at a new 52-week high today of $61.74 ...

Watch for Continued Gains in Shares of S...

Shares of Skyworks Solutions (NASDAQ:SWKS) traded today at $74.18, breaking its 52-week ...